Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Prevention of Vision Loss in Patients With Age-Related Neovascular Macular Degeneration by Intravitreal Injection of Bevacizumab and Ranibizumab in a Typical Outpatient Setting

Authors not listed

Klinikum Bremen-Mitte, gGmbH · 2008

Abstract

The study is designed to demonstrate the therapeutic non-inferiority of the recombinant humanized monoclonal VEGF antibody bevacizumab administered by intravitreal injection in the treatment of AMD in comparison to the related fragment ranibizumab.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-12 MST

Cite this

APA
Anonymous. (2008). Prevention of Vision Loss in Patients With Age-Related Neovascular Macular Degeneration by Intravitreal Injection of Bevacizumab and Ranibizumab in a Typical Outpatient Setting. <em>Klinikum Bremen-Mitte, gGmbH</em>. https://clinicaltrials.gov/study/NCT00559715
Vancouver
Anonymous. Prevention of Vision Loss in Patients With Age-Related Neovascular Macular Degeneration by Intravitreal Injection of Bevacizumab and Ranibizumab in a Typical Outpatient Setting. Klinikum Bremen-Mitte, gGmbH. 2008.
BibTeX
@misc{anon2008Preven, title = {Prevention of Vision Loss in Patients With Age-Related Neovascular Macular Degeneration by Intravitreal Injection of Bevacizumab and Ranibizumab in a Typical Outpatient Setting}, author = {Anonymous}, journal = {Klinikum Bremen-Mitte, gGmbH}, year = {2008}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.